AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced an expansion of its patent infringement lawsuit against ...
Amended complaint asserts infringement of U.S. Patent Nos. ‘596 and ‘454 by the modified version of NeoGenomics’ RaDaR assay AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback